79 results
424B3
Arcturus Therapeutics Holdings, Inc.
12 Apr 19
Prospectus supplement
4:39pm
tax consequences to the Company that may result from this distribution.
While our incorporation in Israel has served us and our shareholders well … ordinary shares and holders of options to purchase ordinary shares will not recognize any gain or loss for U.S. federal income tax purposes
S-4/A
Arcturus Therapeutics Holdings, Inc.
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
of the Company to effect the second step distribution in kind and will consider all relevant factors, including potential tax consequences to the Company … of options to purchase ordinary shares will not recognize any gain or loss for U.S. federal income tax purposes in connection with the transaction
S-4
ARCT
Arcturus Therapeutics Holdings Inc
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
to purchase ordinary shares will not recognize any gain or loss for U.S. federal income tax purposes in connection with the transaction. With regard … to Israeli capital gains taxation, in connection with the Exchange Agreement, Arcturus-Israel will seek apre-ruling (the “Tax Ruling”) on behalf
424B5
ARCT
Arcturus Therapeutics Holdings Inc
17 Apr 20
Prospectus supplement for primary offering
4:02pm
-LOOKING STATEMENTS
S-9
USE OF PROCEEDS
S-11
DIVIDEND POLICY
S-12
DILUTION
S-12
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
S-13 … . FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
The following discussion is a summary of the material U.S. federal income tax consequences
424B5
ARCT
Arcturus Therapeutics Holdings Inc
8 Dec 20
Prospectus supplement for primary offering
5:30pm
. Federal Income Tax Consequences For Non-U.S. Holders Of Our Common Stock
S-17
Underwriting
S-21
Legal Matters
S-26
Experts
S-26
Where You Can Find … Purchase Plan.
S-16
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES
FOR NON-U.S. HOLDERS OF OUR COMMON STOCK
The following is a general discussion
424B5
zb13r7et7w3x0z
30 Jul 20
Prospectus supplement for primary offering
6:01am
S-4/A
EX-8.2
j5wp4o84
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
8-K12B
EX-10.3
v2ilc3s
14 Jun 19
Notification of registration of securities
5:10pm
8-K
EX-10.1
ju1uje 6zsr033
26 Apr 21
Departure of Directors or Certain Officers
5:15pm
424B5
woc11bhtf9ddexo122b
7 Dec 20
Prospectus supplement for primary offering
5:20pm
424B5
s1ixhv rsdi
28 Jul 20
Prospectus supplement for primary offering
4:17pm
424B5
2lnf39 f4kt
15 Apr 20
Prospectus supplement for primary offering
4:14pm
8-K12B
EX-10.2
cwefcj1yn7ngz6tvv
14 Jun 19
Notification of registration of securities
5:10pm
8-K12B
EX-10.1
thxi1r8d
14 Jun 19
Notification of registration of securities
5:10pm
S-4
EX-8.1
dtn2di kz3sqy1hlig
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
10-K
f2dvjvf3ih sbafj
16 Mar 20
Annual report
11:09am